Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Ischemic Heart Disease

Free Subscription Articles published in Am Heart J Retrieve available abstracts of 168 articles: HTML format

Single Articles

June 2022
1. REIFFEL JA
   The safety of flecainide for atrial fibrillation in patients with stable coronary artery disease - Fact or fallacy.
   Am Heart J. 2022;248:163-164.
   PubMed    
   
   
   May 2022
2. HARRINGTON J, Udell JA, Jones WS, Anker SD, et al
   Empagliflozin in Patients Post Myocardial Infarction Rationale and Design of the EMPACT-MI Trial.
   Am Heart J. 2022 May 17. pii: S0002-8703(22)00095.
   PubMed     Abstract available
   
   
   
3. CANTOR WJ, Tan M, Berwanger O, Lavi S, et al
   Morphine and Clinical Outcomes in Patients with ST segment elevation Myocardial Infarction Treated with Fibrinolytic and Antiplatelet Therapy: Insights from the TREAT Trial.
   Am Heart J. 2022 May 6. pii: S0002-8703(22)00089.
   PubMed     Abstract available
   
   
   
4. O'DONOGHUE ML, Lopez JAG, Knusel B, Gencer B, et al
   Study Design and Rationale for the OCEAN(a)-DOSE (Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction-DOSE Finding Study) Trial.
   Am Heart J. 2022 May 6. pii: S0002-8703(22)00086.
   PubMed     Abstract available
   
   
   
5. FORREST IS, Chan L, Chaudhary K, Saha A, et al
   Genome-First Recall of Healthy Individuals by Polygenic Risk Score Reveals Differences in Coronary Artery Calcium.
   Am Heart J. 2022 May 5. pii: S0002-8703(22)00081.
   PubMed     Abstract available
   
   
   
6. DENOBLE AE, Goldstein SA, Wein MLE, Grotegut CA, et al
   Comparison of severe maternal morbidity in pregnancy by modified World Health Organization Classification of maternal cardiovascular risk.
   Am Heart J. 2022 May 5. pii: S0002-8703(22)00084.
   PubMed     Abstract available
   
   
   
7. GAO W, Zhong X, Ma Y, Huang D, et al
   A Randomized Multicenter Trial to Evaluate Early Invasive Strategy for Patients with Acute ST-segment Elevation Myocardial Infarction Presenting 24-48 Hours from Symptom Onset: protocol of the RESCUE-MI study.
   Am Heart J. 2022 May 4. pii: S0002-8703(22)00087.
   PubMed     Abstract available
   
   
   April 2022
8. GARG A, Rout A, Farhan S, Waxman S, et al
   Dual Antiplatelet Therapy Duration after Percutaneous Coronary Intervention using Drug Eluting Stents in High Bleeding Risk Patients: A Systematic Review and Meta-analysis.
   Am Heart J. 2022 Apr 15. pii: S0002-8703(22)00076.
   PubMed     Abstract available
   
   
   
9. BAGIELLA E, Puskas JD, Moskowitz AJ, Gelijns AC, et al
   Rationale and design of a randomized trial evaluating an external support device for saphenous vein coronary grafts.
   Am Heart J. 2022;246:12-20.
   PubMed     Abstract available
   
   
   March 2022
10. UDELL JA, Lu D, Bagai A, Dodson JA, et al
    Preexisting Frailty and Outcomes in Older Patients with Acute Myocardial Infarction.
    Am Heart J. 2022 Mar 23. pii: S0002-8703(22)00056.
    PubMed     Abstract available
    
    
    
11. DUCROCQ G, Bhatt DL, Lee JJ, Kui N, et al
    Balance of Benefit and Risk of Ticagrelor in Patients With Diabetes and Stable Coronary Artery Disease According to Bleeding Risk Assessment With the CRUSADE Score: Data From THEMIS and THEMIS PCI: Abbreviated title: Bleeding risk stratification of ti
    Am Heart J. 2022 Mar 20. pii: S0002-8703(22)00055.
    PubMed     Abstract available
    
    
    
12. ERQOU S, Papaila A, Halladay C, Ge A, et al
    Variation in Statin Prescription among Veterans with HIV and Known Atherosclerotic Cardiovascular Disease.
    Am Heart J. 2022 Mar 19. pii: S0002-8703(22)00054.
    PubMed     Abstract available
    
    
    
13. GENEREUX P, Kirtane AJ, Kandzari DE, Armstrong EJ, et al
    Randomized Evaluation of Vessel Preparation With Orbital Atherectomy Prior to Drug-Eluting Stent Implantation in Severely Calcified Coronary Artery Lesions: Design and Rationale of the ECLIPSE Trial.
    Am Heart J. 2022 Mar 11. pii: S0002-8703(22)00051.
    PubMed     Abstract available
    
    
    
14. TIAN X, Zuo Y, Chen S, Meng X, et al
    Distinct triglyceride-glucose trajectories are associated with different risks of incident cardiovascular disease in normal-weight adults.
    Am Heart J. 2022 Mar 3. pii: S0002-8703(22)00047.
    PubMed     Abstract available
    
    
    
15. NANNA MG, Vemulapalli S, Fordyce CB, Mark DB, et al
    The prospective randomized trial of the optimal evaluation of cardiac symptoms and revascularization: Rationale and design of the PRECISE trial.
    Am Heart J. 2022;245:136-148.
    PubMed     Abstract available
    
    
    February 2022
16. VERMA KP, Marwick T, Duarte C, Meikle P, et al
    Use of Coronary Computed Tomography or Polygenic Risk Scores to Prompt Action to Reduce Coronary Artery Disease Risk: The CAPAR-CAD Trial.
    Am Heart J. 2022 Feb 23. pii: S0002-8703(22)00040.
    PubMed     Abstract available
    
    
    
17. COUCH SC, Helsley RN, Siegel FU, Saelens BE, et al
    Design and Rationale for the Supermarket and Web-Based Intervention Targeting Nutrition (SuperWIN) for Cardiovascular Risk Reduction Trial.
    Am Heart J. 2022 Feb 23. pii: S0002-8703(22)00044.
    PubMed     Abstract available
    
    
    
18. O'NEILL WW, Anderson M, Burkhoff D, Grines CL, et al
    Improved Outcomes in Patients with Severely Depressed LVEF Undergoing Percutaneous Coronary Intervention with Contemporary Practices: Impella-Supported High-Risk Percutaneous Coronary Intervention in Patients with Severely Depressed LVEF.
    Am Heart J. 2022 Feb 19. pii: S0002-8703(22)00039.
    PubMed     Abstract available
    
    
    
19. CHO MS, Kang DY, Oh YS, Lee CH, et al
    Edoxaban-Based Long-Term Antithrombotic Therapy in Patients with Atrial Fibrillation and Stable Coronary Disease: Rationale and Design of the Randomized EPIC-CAD Trial.
    Am Heart J. 2022 Feb 8. pii: S0002-8703(22)00023.
    PubMed     Abstract available
    
    
    
20. SIDHU MS, Alexander KP, Huang Z, O'Brien SM, et al
    Causes of Cardiovascular and Non-Cardiovascular Death in the ISCHEMIA Trial.
    Am Heart J. 2022 Feb 8. pii: S0002-8703(22)00026.
    PubMed     Abstract available
    
    
    
21. HASSAN R, Riehl-Tonn V, Dumanski SM, Lyons KJ, et al
    Female Sex-Specific Cardiovascular Risk Factors and Heart Failure Practice Guidelines.
    Am Heart J. 2022 Feb 4. pii: S0002-8703(22)00008.
    PubMed     Abstract available
    
    
    
22. HORNE BD, Muhlestein JB, Lappe DL, May HT, et al
    Behavioral Nudges as Patient Decision Support for Medication Adherence: The ENCOURAGE Randomized Controlled Trial.
    Am Heart J. 2022;244:125-134.
    PubMed     Abstract available
    
    
    January 2022
23. JAIN B, Bajaj SS, Paguio JA, Yao JS, et al
    Socioeconomic Disparities in Healthcare Utilization for Atherosclerotic Cardiovascular Disease.
    Am Heart J. 2022 Jan 27. pii: S0002-8703(22)00011.
    PubMed     Abstract available
    
    
    
24. KLINGENBERG R, Stahli BE, Heg D, Denegri A, et al
    Controlled-Level EVERolimus in Acute Coronary Syndrome (CLEVER-ACS) - A phase II, randomized, double-blind, multi-center, placebo-controlled trial.
    Am Heart J. 2022 Jan 26. pii: S0002-8703(22)00010.
    PubMed     Abstract available
    
    
    
25. BREWER LC, Jenkins S, Hayes SN, Kumbamu A, et al
    Community-based, cluster-randomized pilot trial of a cardiovascular mHealth intervention: Rationale, design, and baseline findings of the FAITH! Trial.
    Am Heart J. 2022 Jan 20. pii: S0002-8703(22)00009.
    PubMed     Abstract available
    
    
    
26. TIES D, van Dorp P, Pundziute G, van der Aalst CM, et al
    Early detection of obstructive coronary artery disease in the asymptomatic high-risk population: objectives and study design of the EARLY-SYNERGY trial.
    Am Heart J. 2022 Jan 13. pii: S0002-8703(22)00005.
    PubMed     Abstract available
    
    
    
27. OTOWA K, Kohsaka S, Sawano M, Matsuura S, et al
    One-year Outcome after Percutaneous Coronary Intervention in Nonagenarians: Insights from the J-PCI OUTCOME Registry.
    Am Heart J. 2022 Jan 8. pii: S0002-8703(22)00004.
    PubMed     Abstract available
    
    
    
28. TERTULIEN T, Roberts MB, Eaton CB, Cene CW, et al
    Association Between Race/Ethnicity and Income on the Likelihood of Coronary Revascularization Among Postmenopausal Women with Acute Myocardial Infarction: Women's Health Initiative Study.
    Am Heart J. 2022 Jan 6. pii: S0002-8703(21)00496.
    PubMed     Abstract available
    
    
    
29. HARIRI E, Kassas I, Hammoud MA, Hansra B, et al
    Same Day Discharge Following Non-elective PCI for Non-ST Elevation Acute Coronary Syndromes.
    Am Heart J. 2022 Jan 6. pii: S0002-8703(21)00497.
    PubMed     Abstract available
    
    
    
30. HARA H, Serruys PW, O'Leary N, Gao C, et al
    Angiography-derived physiology guidance versus usual care in an All-comers PCI population treated with the Healing-Targeted Supreme stent and Ticagrelor monotherapy: PIONEER IV trial design.
    Am Heart J. 2022 Jan 3. pii: S0002-8703(21)00500.
    PubMed     Abstract available
    
    
    
31. BAINEY KR, Fleg JL, Hochman JS, Kunichoff DF, et al
    Predictors of outcome in the ISCHEMIA-CKD trial: Anatomy versus ischemia.
    Am Heart J. 2022;243:187-200.
    PubMed     Abstract available
    
    
    December 2021
32. RIFAI MA, Mahtta D, Ramsey DJ, Lee MT, et al
    nCorrelates of SGLT-2-inhibitiors Use Among Patients with Atherosclerotic Cardiovascular Disease and Type 2 Diabetes Mellitus: Insights from the Department of Veterans Affairs.
    Am Heart J. 2021 Dec 27. pii: S0002-8703(21)00480.
    PubMed     Abstract available
    
    
    
33. HSU B, Carcel C, Wang X, Peters SAE, et al
    Erratum to "Sex differences in emergency medical services management of patients with myocardial infarction: Analysis of routinely collected data for over 110,000 patients" [Am Heart J (2021) 87-91].
    Am Heart J. 2021 Dec 24. pii: S0002-8703(21)00451.
    PubMed    
    
    
    
34. BURSTEIN B, Anand V, Ternus B, Tabi M, et al
    Noninvasive Echocardiographic Cardiac Power Output Predicts Mortality in Cardiac Intensive Care Unit Patients.
    Am Heart J. 2021 Dec 22. pii: S0002-8703(21)00479.
    PubMed     Abstract available
    
    
    
35. SIDHU MS, Lyubarova R, Bangalore S, Bonaca MP, et al
    Challenges of Long-term Dual Antiplatelet Therapy Use Following Acute Coronary Syndromes: Patient Selection for Long-term DAPT After ACS.
    Am Heart J. 2021 Dec 18. pii: S0002-8703(21)00478.
    PubMed     Abstract available
    
    
    
36. VEMULAPALLI S, Kerr MSD, Roberts GJ, Prillinger JB, et al
    Tricuspid Valve Disease Prevalence and the Impact of Tricuspid Valve Surgery on Cardiovascular Events and Hospital Resource Use in Medicare Beneficiaries.
    Am Heart J. 2021 Dec 18. pii: S0002-8703(21)00469.
    PubMed     Abstract available
    
    
    
37. PASALA S, Cooper LB, Psotka MA, Sinha SS, et al
    The Influence of Heart Failure on Clinical and Economic Outcomes among Older Adult >/=75 Years of Age with Acute Myocardial Infarction.
    Am Heart J. 2021 Dec 16. pii: S0002-8703(21)00474.
    PubMed     Abstract available
    
    
    
38. SIEGMUND AS, Pieper PG, Bilardo CM, Gordijn SJ, et al
    Cardiovascular Determinants of Impaired Placental Function in Women with Cardiac Dysfunction.
    Am Heart J. 2021 Dec 10. pii: S0002-8703(21)00473.
    PubMed     Abstract available
    
    
    
39. ACQUAH I, Hagan K, Valero-Elizondo J, Javed Z, et al
    Delayed Medical Care due to Transportation Barriers Among Adults with Atherosclerotic Cardiovascular Disease.
    Am Heart J. 2021 Dec 10. pii: S0002-8703(21)00472.
    PubMed     Abstract available
    
    
    
40. CHRISTENSEN DM, Schjerning AM, Sindet-Pedersen C, Lamberts M, et al
    Outcomes of prolonged dual anti-platelet therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a nationwide registry-based study.
    Am Heart J. 2021 Dec 10. pii: S0002-8703(21)00471.
    PubMed     Abstract available
    
    
    
41. BHASIN S, Lincoff AM, Basaria S, Bauer DC, et al
    Effects of Long-term Testosterone Treatment on Cardiovascular Outcomes in Men with Hypogonadism: Rationale and Design of the TRAVERSE Study.
    Am Heart J. 2021 Dec 3. pii: S0002-8703(21)00467.
    PubMed     Abstract available
    
    
    
42. MONTOY JCC, Shen YC, Krumholz HM, Hsia RY, et al
    Association of STEMI regionalization of care with de facto NSTEMI regionalization.
    Am Heart J. 2021;242:1-5.
    PubMed     Abstract available
    
    
    November 2021
43. AKHABUE E, Wong M, Mehta R, Isakova T, et al
    Fibroblast Growth Factor-23 and Subclinical Markers of Cardiac Dysfunction: The Coronary Artery Risk Development in Young Adults (CARDIA) Study.
    Am Heart J. 2021 Nov 30. pii: S0002-8703(21)00460.
    PubMed     Abstract available
    
    
    
44. HUANG D, Wu H, Zhou J, Zhong X, et al
    Intravenous Nicorandil During Primary Percutaneous Coronary intervention in Patients with ST-Elevation Myocardial Infarction: Rationale and Design of the CLinical Efficacy and sAfety of intravenous Nicorandil (CLEAN) trial.
    Am Heart J. 2021 Nov 13. pii: S0002-8703(21)00448.
    PubMed     Abstract available
    
    
    
45. KOSHY AN, Dinh DT, Fulcher J, Brennan AL, et al
    Long-Term Mortality in Asymptomatic Patients with Stable Ischemic Heart Disease undergoing Percutaneous Coronary Intervention.
    Am Heart J. 2021 Nov 12. pii: S0002-8703(21)00449.
    PubMed     Abstract available
    
    
    
46. VALLABHAJOSYULA S, Bhopalwala HM, Sundaragiri PR, Dewaswala N, et al
    Cardiogenic Shock Complicating Non-ST-Segment Elevation Myocardial Infarction: An 18-Year Study.
    Am Heart J. 2021 Nov 11. pii: S0002-8703(21)00445.
    PubMed     Abstract available
    
    
    
47. MERT GO, Babayigit E, Gorenek B
    The value of performing thorough echocardiography in patients with coronary heart disease and atrial fibrillation.
    Am Heart J. 2021;241:121.
    PubMed    
    
    
    
48. BOHM F, Mogensen B, Ostlund O, Engstrom T, et al
    The Full Revasc (Ffr-gUidance for compLete non-cuLprit REVASCularization) Registry-based randomized clinical trial.
    Am Heart J. 2021;241:92-100.
    PubMed     Abstract available
    
    
    October 2021
49. REDDY NK, Kaushal V, Kanaya AM, Kandula NR, et al
    Cardiovascular risk factor profiles in North and South Indian and Pakistani Americans: The MASALA Study.
    Am Heart J. 2021 Oct 21. pii: S0002-8703(21)00367.
    PubMed     Abstract available
    
    
    
50. AMINIAN A, Sgueglia GA, Wiemer M, Gasparini GL, et al
    Distal versus conventional radial access for coronary angiography and intervention: design and rationale of DISCO RADIAL Study.
    Am Heart J. 2021 Oct 16. pii: S0002-8703(21)00432.
    PubMed     Abstract available
    
    
    
51. WEAVER AM, McGuinn LA, Neas L, Devlin RB, et al
    Associations between neighborhood socioeconomic cluster and hypertension, diabetes, myocardial infarction, and coronary artery disease within a cohort of cardiac catheterization patients.
    Am Heart J. 2021 Oct 2. pii: S0002-8703(21)00243.
    PubMed     Abstract available
    
    
    September 2021
52. PANKAYATSELVAN V, Mukamal KJ
    Influenza Vaccination Among Adults with Cardiovascular Disease in the United States: Results from the Behavioral Risk Factor Surveillance System 2018-2019.
    Am Heart J. 2021 Sep 29. pii: S0002-8703(21)00233.
    PubMed     Abstract available
    
    
    
53. CAINZOS-ACHIRICA M, Anugula D, Mszar R, Grandhi G, et al
    Rationale and Pathways Forward in the Implementation of Coronary Artery Calcium-Based Enrichment of Randomized Trials.
    Am Heart J. 2021 Sep 26. pii: S0002-8703(21)00235.
    PubMed     Abstract available
    
    
    
54. SALAH HM, Khan Minhas AM, Khan MS, Khan SU, et al
    Trends in Hospitalizations for Heart Failure, Acute Myocardial Infarction, and Stroke in the United States from 2004-2018.
    Am Heart J. 2021 Sep 25. pii: S0002-8703(21)00238.
    PubMed     Abstract available
    
    
    
55. YIN Y, Fang C, Jiang S, Wang J, et al
    In vivo evidence of atherosclerotic plaque erosion and healing in patients with acute coronary syndrome using serial optical coherence tomography imaging.
    Am Heart J. 2021 Sep 25. pii: S0002-8703(21)00236.
    PubMed     Abstract available
    
    
    
56. PAPADOPOULOS EJ, Stein KM, Voloshko P, Seltzer J, et al
    The COVID-19 Pandemic and Cardiovascular Issues in Clinical Trials: Practical and Regulatory Issues in Remote Monitoring of Cardiac Safety.
    Am Heart J. 2021 Sep 20. pii: S0002-8703(21)00234.
    PubMed    
    
    
    
57. TAVENIER AH, Hermanides RS, Ottervanger JP, Belitser SV, et al
    Impact of vomiting on P2Y12 platelet inhibition in patients with ST-elevation myocardial infarction: a pre-specified sub-analysis of the ON-TIME 3 trial.
    Am Heart J. 2021 Sep 18. pii: S0002-8703(21)00209.
    PubMed     Abstract available
    
    
    
58. BURNHAM TS, May HT, Bair TL, Anderson JA, et al
    Long-term Outcomes in Patients Treated with Flecainide for Atrial Fibrillation with Stable Coronary Artery Disease.
    Am Heart J. 2021 Sep 16. pii: S0002-8703(21)00211.
    PubMed     Abstract available
    
    
    
59. DE KONING MLY, van Dorp P, Assa S, Hartman MHT, et al
    Rationale and Design of the Groningen Intervention Study for the Preservation of Cardiac Function with Sodium Thiosulfate after ST-segment Elevation Myocardial Infarction (GIPS-IV) Trial.
    Am Heart J. 2021 Sep 14. pii: S0002-8703(21)00210.
    PubMed     Abstract available
    
    
    
60. CAVENDER MA, O'Donoghue M, Abbate A, Aylward P, et al
    Inhibition of p38 MAP Kinase in Patients with ST-Elevation Myocardial Infarction - Findings from the LATITUDE TIMI 60 Trial.
    Am Heart J. 2021 Sep 8. pii: S0002-8703(21)00229.
    PubMed     Abstract available
    
    
    
61. KOECHLIN L, Boeddinghaus J, Nestelberger T, Lopez-Ayala P, et al
    Performance of the ESC 0/2h-Algorithm using High-Sensitivity Cardiac Troponin I in the Early Diagnosis of Myocardial Infarction.
    Am Heart J. 2021 Sep 8. pii: S0002-8703(21)00206.
    PubMed     Abstract available
    
    
    
62. NANNA MG, Wang TY, Chiswell K, Sun JL, et al
    Estimating the real-world performance of the PROMISE minimal-risk tool.
    Am Heart J. 2021;239:100-109.
    PubMed     Abstract available
    
    
    
63. NARCISSE DI, Ford CB, Weissler EH, Lippmann SJ, et al
    The association of healthcare disparities and patient-specific factors on clinical outcomes in peripheral artery disease.
    Am Heart J. 2021;239:135-146.
    PubMed     Abstract available
    
    
    
64. BARBERY CE, Giczewska A, White J, Lokhnygina Y, et al
    Effect of once-weekly exenatide on hospitalization for acute coronary syndrome or coronary revascularization in patients with type 2 diabetes mellitus.
    Am Heart J. 2021;239:59-63.
    PubMed     Abstract available
    
    
    August 2021
65. DAWWAS GK, Barnes GD, Dietrich E, Cuker A, et al
    Cardiovascular and major bleeding outcomes with antiplatelet and direct oral anticoagulants in patients with acute coronary syndrome and atrial fibrillation A population-based analysis.
    Am Heart J. 2021 Aug 24. pii: S0002-8703(21)00212.
    PubMed     Abstract available
    
    
    
66. KLIMIS H, Thiagalingam A, McIntyre D, Marschner S, et al
    Text messages for primary prevention of cardiovascular disease: The TextMe2 Randomised Clinical Trial.
    Am Heart J. 2021 Aug 21. pii: S0002-8703(21)00207.
    PubMed     Abstract available
    
    
    
67. VEMULAPALLI S, Stebbins A, Jones WS, Gutierrez JA, et al
    Cardiovascular Risk and Outcomes in Symptomatic Patients with Suspected CAD and Non Coronary Vascular Disease: A Report from the PROMISE Trial.
    Am Heart J. 2021 Aug 9. pii: S0002-8703(21)00196.
    PubMed     Abstract available
    
    
    July 2021
68. HSU B, Carcel C, Wang X, Peters SAE, et al
    Sex differences in emergency medical services management of patients with myocardial infarction: analysis of routinely collected data for over 110,000 patients.
    Am Heart J. 2021 Jul 24. pii: S0002-8703(21)00188.
    PubMed     Abstract available
    
    
    
69. CHRISTENSEN DM, Butt JH, Fosbol E, Kober L, et al
    Admission Rates During a Second COVID-19 Lockdown.
    Am Heart J. 2021 Jul 15. pii: S0002-8703(21)00180.
    PubMed     Abstract available
    
    
    
70. HANDBERG EM, Merz CNB, Cooper-Dehoff RM, Wei J, et al
    Rationale and design of the Women's Ischemia Trial to Reduce Events in Nonobstructive CAD (WARRIOR) trial.
    Am Heart J. 2021;237:90-103.
    PubMed     Abstract available
    
    
    June 2021
71. YONG CM, Spinelli KJ, Chiu ST, Jones B, et al
    Cardiovascular Procedural Deferral and Outcomes over COVID-19 Pandemic Phases: A Multi-Center Study.
    Am Heart J. 2021 Jun 25. pii: S0002-8703(21)00167.
    PubMed     Abstract available
    
    
    
72. FERNANDEZ-ALVIRA JM, Fernandez-Jimenez R, de Miguel M, Santos-Beneit G, et al
    The challenge of sustainability: long-term results from the Fifty-Fifty peer group-based intervention in cardiovascular risk factors.
    Am Heart J. 2021 Jun 17. pii: S0002-8703(21)00162.
    PubMed     Abstract available
    
    
    
73. COTTER G, Davison BA, Edwards C, Senger S, et al
    Regional variation of effects of new antidiabetic medications in cardiovascular outcome trials.
    Am Heart J. 2021 Jun 6. pii: S0002-8703(21)00148.
    PubMed     Abstract available
    
    
    
74. PICICHE M, Biondi-Zoccai G, Del Prete A, Versaci F, et al
    "Effect of permanent right internal mammary artery occlusion on right coronary artery supply: A randomized placebo-controlled clinical trial".
    Am Heart J. 2021;236:100-101.
    PubMed    
    
    
    
75. KUNO T, Ueyama H, Rao SV, Cohen MG, et al
    Future Perspectives of Left Main Revascularization Trials.
    Am Heart J. 2021;236:109.
    PubMed    
    
    
    
76. HU X, Wang Y
    Importance of complete revascularization and surgical techniques when comparing outcomes of CABG with PCI.
    Am Heart J. 2021;236:107-108.
    PubMed    
    
    
    
77. KONTOS MC, Diercks DB
    High Sensitivity Troponins and Ischemia Testing: Are We Doing Too Much?
    Am Heart J. 2021;236:97-99.
    PubMed    
    
    
    May 2021
78. BAJAJ R, Parasa R, Ramasamy A, Makariou N, et al
    Computerized technologies informing cardiac catheterization and guiding coronary intervention.
    Am Heart J. 2021 May 30. pii: S0002-8703(21)00146.
    PubMed     Abstract available
    
    
    
79. MONEY JE, Muhlestein JB, Mason S, Bair TL, et al
    Simplifying the ISCHEMIA Trial Algorithm for Clinical Practice: Identifying Left Main Coronary Artery Disease Using Coronary Artery Calcium Scans.
    Am Heart J. 2021 May 26. pii: S0002-8703(21)00142.
    PubMed     Abstract available
    
    
    
80. TINTUT Y, Demer LL
    Potential Impact of the Steroid Hormone, Vitamin D, on the Vasculature Vitamin D-hormones and cardiovascular disease.
    Am Heart J. 2021 May 26. pii: S0002-8703(21)00141.
    PubMed     Abstract available
    
    
    
81. ONO M, Serruys PW, Patel MR, Escaned J, et al
    A Prospective Multicenter Validation Study for A Novel Angiography-derived Physiological Assessment Software: Rationale and Design of the Radiographic imaging Validation and EvALuation for Angio-iFR (ReVEAL iFR) study.
    Am Heart J. 2021 May 13. pii: S0002-8703(21)00124.
    PubMed     Abstract available
    
    
    
82. SLAVIN SD, Khera R, Zafar SY, Nasir K, et al
    Financial Burden, Distress and Toxicity in Cardiovascular Disease.
    Am Heart J. 2021 May 4. pii: S0002-8703(21)00113.
    PubMed     Abstract available
    
    
    
83. YERASI C, Case BC, Chezar-Azerrad C, Forrestal BJ, et al
    Cangrelor vs. Glycoprotein IIb/IIIa Inhibitors During Percutaneous Coronary Intervention.
    Am Heart J. 2021 May 4. pii: S0002-8703(21)00115.
    PubMed     Abstract available
    
    
    
84. MADSEN JMM, Jacobsen MRR, Sabbah M, Topal DGG, et al
    Long-Term Prognostic Outcomes and Implication of Oral Anticoagulants in Patients with New-Onset Atrial Fibrillation following ST-Segment Elevation Myocardial Infarction.
    Am Heart J. 2021 May 3. pii: S0002-8703(21)00114.
    PubMed     Abstract available
    
    
    
85. SIDEBOTTOM AC, Miedema MD, Benson G, Vacquier M, et al
    The Impact of a Population-based Prevention Program on Cardiovascular Events: Findings from the Heart of New Ulm Project.
    Am Heart J. 2021 May 3. pii: S0002-8703(21)00112.
    PubMed     Abstract available
    
    
    
86. SHI X, He J, Lin M, Liu C, et al
    Comparative effectiveness of team-based care with a clinical decision support system versus team-based care alone on cardiovascular risk reduction among patients with diabetes: Rationale and design of the D4C trial.
    Am Heart J. 2021 May 3. pii: S0002-8703(21)00111.
    PubMed     Abstract available
    
    
    
87. ZANCHIN C, Koskinas KC, Ueki Y, Losdat S, et al
    Effects of the PCSK9 Antibody Alirocumab on Coronary Atherosclerosis in Patients with Acute Myocardial Infarction: A Serial, Multivessel, Intravascular Ultrasound, Near-Infrared Spectroscopy and Optical Coherence Tomography Imaging Study Rationale and
    Am Heart J. 2021 May 2. pii: S0002-8703(21)00108.
    PubMed     Abstract available
    
    
    April 2021
88. SINGH H, Mehta RH, O'Neill W, Kapur NK, et al
    Clinical Features and Outcomes in Patients with Cardiogenic Shock Complicating Acute Myocardial Infarction: Early versus Recent Experience with Impella.
    Am Heart J. 2021 Apr 10. pii: S0002-8703(21)00090.
    PubMed     Abstract available
    
    
    March 2021
89. KITKUNGVAN D, Johnson NP, Kirkeeide R, Haynie M, et al
    Design and Rationale of The Randomized Trial of Comprehensive LifEstyle ModificatioN, Optimal Pharmacological Treatment and Utilizing PET Imaging for Quantifying and Managing Stable CoronaRy ArterY Disease (The CENTURY Study).
    Am Heart J. 2021 Mar 21. pii: S0002-8703(21)00078.
    PubMed     Abstract available
    
    
    
90. FUJISAKI T, Kuno T, Ando T, Briasoulis A, et al
    Potent P2Y12 Inhibitors versus Clopidogrel in Elderly Patients with Acute Coronary Syndrome: Systematic Review and Meta-Analysis: P2Y12 inhibitors and elderly patients with ACS.
    Am Heart J. 2021 Mar 15. pii: S0002-8703(21)00075.
    PubMed     Abstract available
    
    
    
91. ETMINAN M, Brophy JM, Collins G, Nazemipour M, et al
    Curriculum in Cardiology To Adjust or Not to Adjust: The Role of Different Covariates in Cardiovascular Observational Studies.
    Am Heart J. 2021 Mar 12. pii: S0002-8703(21)00073.
    PubMed     Abstract available
    
    
    
92. HOLLINGSWORTH R, Palmu A, Pepin S, Dupuy M, et al
    Effectiveness of the quadrivalent high-dose influenza vaccine for prevention of cardiovascular and respiratory events in people aged 65 years and above: rationale and design of a real-world pragmatic randomized clinical trial.
    Am Heart J. 2021 Mar 12. pii: S0002-8703(21)00072.
    PubMed     Abstract available
    
    
    
93. ALFREDSSON J, James SK, Erlinge D, Herlitz J, et al
    Randomized comparison of early supplemental oxygen versus ambient air in patients with confirmed myocardial infarction: Sex related outcomes from DETO2X-AMI.
    Am Heart J. 2021 Mar 6. pii: S0002-8703(21)00066.
    PubMed     Abstract available
    
    
    
94. QU J, Du J, Rao C, Chen S, et al
    Effect of a Smartphone-Based Intervention on Secondary Prevention Medication Prescriptions After Coronary Artery Bypass Graft Surgery: The MISSION-1 Randomized Controlled Trial.
    Am Heart J. 2021 Mar 6. pii: S0002-8703(21)00070.
    PubMed     Abstract available
    
    
    
95. FABRIS E, Ten Berg JM, Hermanides RS, Ottervanger JP, et al
    NT-proBNP level before primary PCI and risk of poor myocardial reperfusion: Insight from the On-TIME II trial.
    Am Heart J. 2021;233:78-85.
    PubMed     Abstract available
    
    
    February 2021
96. AKAO M, Yasuda S, Kaikita K, Ako J, et al
    Rivaroxaban Monotherapy versus Combination Therapy According to Patient Risk of Stroke and Bleeding in Atrial Fibrillation and Stable Coronary Disease: AFIRE trial sub-analysis.
    Am Heart J. 2021 Feb 28. pii: S0002-8703(21)00063.
    PubMed     Abstract available
    
    
    
97. BATCHELOR WB, Damluji AA, Yong C, Fiuzat M, et al
    DOES STUDY SUBJECT DIVERSITY INFLUENCE CARDIOLOGY RESEARCH SITE PERFORMANCE?: INSIGHTS FROM 2 U.S. NATIONAL CORONARY STENT REGISTRIES.
    Am Heart J. 2021 Feb 23. pii: S0002-8703(21)00035.
    PubMed     Abstract available
    
    
    
98. SUZUKI T, Salzano A, Israr MZ
    Targeting the gut microbiome in coronary artery disease.
    Am Heart J. 2021 Feb 22. pii: S0002-8703(21)00056.
    PubMed    
    
    
    
99. TANG WHW, Li XS, Wu Y, Wang Z, et al
    Plasma trimethylamine N-oxide (TMAO) levels predict future risk of coronary artery disease in apparently healthy individuals in the EPIC-Norfolk Prospective Population Study.
    Am Heart J. 2021 Feb 21. pii: S0002-8703(21)00057.
    PubMed     Abstract available
    
    
    
100. GE Z, Gao XF, Kan J, Kong XQ, et al
     Comparison of 1-month Versus 12-month Dual Antiplatelet Therapy after Implantation of Drug-eluting Stents Guided by either Intravascular Ultrasound or Angiography in Patients with Acute Coronary Syndrome: Rationale and Design of Prospective, Multicent
     Am Heart J. 2021 Feb 20. pii: S0002-8703(21)00053.
     PubMed     Abstract available
     
     
     
101. SHAHZEB KHAN M, Kristensen SL, Vaduganathan M, Kober L, et al
     Natriuretic Peptide Plasma Concentrations and Risk of Cardiovascular Versus Non-Cardiovascular Events in Heart Failure with Reduced Ejection Fraction Insights from the PARADIGM-HF and ATMOSPHERE Trials.
     Am Heart J. 2021 Feb 20. pii: S0002-8703(21)00054.
     PubMed     Abstract available
     
     
     
102. PILGRIM T, Rothenbuhler M, Siontis GC, Kandzari DE, et al
     Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients undergoing percutaneous coronary intervention: a meta-analysis of individual patient data from five randomized trials.
     Am Heart J. 2021 Feb 17. pii: S0002-8703(21)00048.
     PubMed     Abstract available
     
     
     
103. BEVAN GH, Freedman DA, Lee EK, Rajagopalan S, et al
     Association between Ambient Air Pollution and County-Level Cardiovascular Mortality in the United States by Social Deprivation Index.
     Am Heart J. 2021 Feb 13. pii: S0002-8703(21)00037.
     PubMed     Abstract available
     
     
     
104. CAPELL WH, Barnathan ES, Piazza G, Spyropoulos AC, et al
     Rationale and Design for the Study of Rivaroxaban to Reduce Thrombotic Events, Hospitalization and Death in Outpatients with COVID-19: the PREVENT-HD Study.
     Am Heart J. 2021 Feb 9. pii: S0002-8703(21)00033.
     PubMed     Abstract available
     
     
     
105. PRABHU KM, Don C, Sayre GG, Kearney KE, et al
     Interventional Cardiologists' Perceptions of Percutaneous Coronary Intervention Quality Measurement and Feedback.
     Am Heart J. 2021 Feb 7. pii: S0002-8703(21)00032.
     PubMed     Abstract available
     
     
     
106. BROPHY TJ, Warsavage TJ, Hebbe AL, Plomondon ME, et al
     Percutaneous Coronary Intervention in Patients with Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction: Insights from the VA CART Program.
     Am Heart J. 2021 Feb 7. pii: S0002-8703(21)00034.
     PubMed     Abstract available
     
     
     
107. JENTZER JC, Ahmed AM, Vallabhajosyula S, Burstein B, et al
     Shock in the cardiac intensive care unit: Changes in epidemiology and prognosis over time.
     Am Heart J. 2021;232:94-104.
     PubMed     Abstract available
     
     
     
108. BRAIK N, Guedeney P, Behnes M, Desch S, et al
     Impact of chronic total occlusion and revascularization strategy in patients with infarct-related cardiogenic shock: A subanalysis of the culprit-shock trial.
     Am Heart J. 2021;232:185-193.
     PubMed     Abstract available
     
     
     
109. SNAVELY AC, Hendley N, Stopyra JP, Lenoir KM, et al
     Sex and race differences in safety and effectiveness of the HEART pathway accelerated diagnostic protocol for acute chest pain.
     Am Heart J. 2021;232:125-136.
     PubMed     Abstract available
     
     
     January 2021
110. AMBROSY AP, Malik UI, Thomas RC, Parikh RV, et al
     Rationale and Design of the Pragmatic Randomized Trial of Icosapent Ethyl for High Cardiovascular Risk Adults (MITIGATE).
     Am Heart J. 2021 Jan 28. pii: S0002-8703(21)00031.
     PubMed     Abstract available
     
     
     
111. OLIVEIRA RS, Schneider BC, Callo-Quinte G, Oliveira IO, et al
     Prevalence of ideal cardiovascular health in young adults: A birth cohort from southern Brazil.
     Am Heart J. 2021 Jan 25. pii: S0002-8703(21)00018.
     PubMed     Abstract available
     
     
     
112. SAWANO M, Spertus JA, Masoudi FA, Rumsfeld JS, et al
     Bleeding Avoidance Strategies and Percutaneous Coronary Intervention Outcomes: A Ten-year Observation from a Japanese Multicenter Registry: Post-PCI Bleeding Avoidance and Outcomes.
     Am Heart J. 2021 Jan 17. pii: S0002-8703(21)00014.
     PubMed     Abstract available
     
     
     
113. GE Z, Kan J, Gao XF, Kong XQ, et al
     Comparison of intravascular ultrasound-guided with angiography-guided double kissing crush stenting for patients with complex coronary bifurcation lesions: rationale and design of a prospective, randomized and multicenter DKCRUSH VIII trial.
     Am Heart J. 2021 Jan 16. pii: S0002-8703(21)00015.
     PubMed     Abstract available
     
     
     
114. ZHAO Y, Sivaswamy A, Lee MK, Izadnegahdar M, et al
     A Feasibility Study for CODE-MI: High-Sensitivity Cardiac Troponin - Optimizing the Diagnosis of Acute Myocardial Infarction/Injury in Women.
     Am Heart J. 2021 Jan 15. pii: S0002-8703(21)00012.
     PubMed     Abstract available
     
     
     
115. ADACHI Y, Yamamoto M, Shimura T, Yamaguchi R, et al
     Late kidney injury after transcatheter aortic valve replacement.
     Am Heart J. 2021 Jan 14. pii: S0002-8703(21)00011.
     PubMed     Abstract available
     
     
     
116. YANKEY GS, Jackson LR, Marts C, Chiswell K, et al
     African American-Caucasian American Differences in Aortic Valve Replacement in Patients with Severe Aortic Stenosis: Racial Differences in AVR.
     Am Heart J. 2021 Jan 13. pii: S0002-8703(21)00009.
     PubMed     Abstract available
     
     
     
117. THIELE H, Freund A, Gimenez MR, de Waha-Thiele S, et al
     Extracorporeal life support in patients with acute myocardial infarction complicated by cardiogenic shock - Design and rationale of the ECLS-SHOCK trial.
     Am Heart J. 2021 Jan 8. pii: S0002-8703(21)00004.
     PubMed     Abstract available
     
     
     
118. MARBACH JA, Wells G, Santo PD, So D, et al
     Acute Kidney Injury after Radial or Femoral Artery Access in ST-Segment Elevation Myocardial Infarction: AKI-SAFARI.
     Am Heart J. 2021 Jan 7. pii: S0002-8703(21)00001.
     PubMed     Abstract available
     
     
     
119. FAGEL ND, Amoroso G, Vink MA, Slagboom T, et al
     An immediate or early invasive strategy in non-ST-elevation acute coronary syndrome: the OPTIMA-2 randomized controlled trial.
     Am Heart J. 2021 Jan 7. pii: S0002-8703(21)00003.
     PubMed     Abstract available
     
     
     
120. BAO X, Borne Y, Xu B, Orho-Melander M, et al
     Growth differentiation factor-15 is a biomarker for all-cause mortality but less evident for cardiovascular outcomes: a prospective study: Abbreviated title: GDF-15, all-cause mortality and CVD.
     Am Heart J. 2021 Jan 6. pii: S0002-8703(21)00002.
     PubMed     Abstract available
     
     
     
121. TOMASDOTTIR M, Held C, Hadziosmanovic N, Westerbergh J, et al
     Risk Markers of Incident Atrial Fibrillation in Patients with Coronary Heart Disease.
     Am Heart J. 2021 Jan 2. pii: S0002-8703(20)30425.
     PubMed     Abstract available
     
     
     
122. SMILOWITZ NR, Subashchandran V, Yuriditsky E, Horowitz JM, et al
     Thrombosis in hospitalized patients with viral respiratory infections versus COVID-19.
     Am Heart J. 2021;231:93-95.
     PubMed     Abstract available
     
     
     
123. CIOFANI JL, Han D, Allahwala UK, Asrress KN, et al
     Internet search volume for chest pain during the COVID-19 pandemic.
     Am Heart J. 2021;231:157-159.
     PubMed     Abstract available
     
     
     
124. LAURIDSEN MD, Moller JE, Kober L, Fosbol EL, et al
     Reply to: Letter to the editor: Breaking the trend in cardiogenic shock-From door-to-balloon to door-to-support.
     Am Heart J. 2021;231:161.
     PubMed    
     
     
     
125. XU J, Leung DY, Lo S
     Letter to the editor: Breaking the trend in cardiogenic shock-From door-to-balloon to door-to-support.
     Am Heart J. 2021;231:160.
     PubMed    
     
     
     
126. VALGIMIGLI M, Cao D, Makkar RR, Bangalore S, et al
     Design and rationale of the XIENCE short DAPT clinical program: An assessment of the safety of 3-month and 1-month DAPT in patients at high bleeding risk undergoing PCI with an everolimus-eluting stent.
     Am Heart J. 2021;231:147-156.
     PubMed     Abstract available
     
     
     December 2020
127. SALAH HM, Al'Aref SJ, Khan MS, Al-Hawwas M, et al
     Effects of Sodium-Glucose Cotransporter 1 and 2 Inhibitors on Cardiovascular and Kidney Outcomes in Type 2 Diabetes: A Meta-analysis Update.
     Am Heart J. 2020 Dec 29. pii: S0002-8703(20)30406.
     PubMed     Abstract available
     
     
     
128. MCCORD J, Hana A, Cook B, Hudson MP, et al
     The Role of Cardiac Testing with the 0/1-Hour High-Sensitivity Cardiac Troponin Algorithm Evaluating for Acute Myocardial Infarction.
     Am Heart J. 2020 Dec 26. pii: S0002-8703(20)30417.
     PubMed     Abstract available
     
     
     
129. THANGAM M, Luke AA, Amin AP, Lasala J, et al
     Sociodemographic differences in utilization and outcomes for temporary cardiovascular mechanical support in the setting of cardiogenic shock.
     Am Heart J. 2020 Dec 23. pii: S0002-8703(20)30416.
     PubMed     Abstract available
     
     
     
130. MALIK AO, Amin A, Kennedy K, Qintar M, et al
     Patient-centered contrast thresholds to reduce acute kidney injury in high-risk patients undergoing percutaneous coronary intervention.
     Am Heart J. 2020 Dec 23. pii: S0002-8703(20)30415.
     PubMed     Abstract available
     
     
     
131. SARRAJU A, Li J, Cannon CP, Chang TI, et al
     Effects of Canagliflozin on Cardiovascular, Renal, and Safety Outcomes in Participants With Type 2 Diabetes and Chronic Kidney Disease According to History of Heart Failure: Results From the CREDENCE Trial.
     Am Heart J. 2020 Dec 20. pii: S0002-8703(20)30407.
     PubMed     Abstract available
     
     
     
132. ZHEUTLIN AR, Caldwell DJ, Al Danaf J, Shah RU, et al
     Prevalence of Control Groups in Cardiovascular Clinical Trials: An Analysis of ClinicalTrials.gov from 2009 through 2019.
     Am Heart J. 2020 Dec 18. pii: S0002-8703(20)30405.
     PubMed     Abstract available
     
     
     
133. NUCCIA M, Claudia M, Alice S, Guido T, et al
     Early intra-aortic balloon pump in acute decompensated heart failure complicated by cardiogenic shock: rationale and design of the randomized Altshock- 2 trial.
     Am Heart J. 2020 Dec 15. pii: S0002-8703(20)30399.
     PubMed     Abstract available
     
     
     
134. WARRAICH HJ, Wolf SP, Troy J, Swetz KM, et al
     Differences Between Patients with Cardiovascular Disease and Cancer Referred for Palliative Care.
     Am Heart J. 2020 Dec 8. pii: S0002-8703(20)30398.
     PubMed     Abstract available
     
     
     
135. CHOUDHARY R, Kumari V
     Aspirin versus P2Y12 inhibitor-based monotherapy after percutaneous coronary intervention.
     Am Heart J. 2020;230:99.
     PubMed    
     
     
     
136. SAMSKY MD, Krucoff MW, Morrow DA, Abraham WT, et al
     Cardiac safety research consortium "shock II" think tank report: Advancing practical approaches to generating evidence for the treatment of cardiogenic shock.
     Am Heart J. 2020;230:93-97.
     PubMed    
     
     
     
137. DE LA PAZ A, Orgel R, Hartsell SE, Pauley E, et al
     Getting cardiogenic shock patients to the right place-How initial intensive care unit triage decisions impact processes of care and outcomes.
     Am Heart J. 2020;230:66-70.
     PubMed     Abstract available
     
     
     November 2020
138. OSTERGAARD L, Butt JH, Kragholm K, Schou M, et al
     Incidence of acute coronary syndrome during national lock-down: insights from nationwide data during the coronavirus disease 2019 (COVID-19) pandemic.
     Am Heart J. 2020 Nov 5. pii: S0002-8703(20)30371.
     PubMed     Abstract available
     
     
     
139. DAYAN V, Myers P
     Comparing apples and oranges and adding inches to meters: Is this the way to conduct rigorous meta-analyses of PCI versus CABG in left main coronary disease?
     Am Heart J. 2020;229:180-181.
     PubMed    
     
     
     
140. KUNO T, Ueyama H, Rao SV, Cohen MG, et al
     Meta-analysis of PCI vs. CABG for left main disease revisited.
     Am Heart J. 2020;229:178-179.
     PubMed    
     
     
     
141. MORROW AJ, Ford TJ, Mangion K, Kotecha T, et al
     Rationale and design of the Medical Research Council's Precision Medicine with Zibotentan in Microvascular Angina (PRIZE) trial.
     Am Heart J. 2020;229:70-80.
     PubMed     Abstract available
     
     
     October 2020
142. WARME J, Sundqvist M, Mars K, Aladellie L, et al
     Helicobacter pylori screening in clinical routine during hospitalization for acute myocardial infarction: Rational and feasibility.
     Am Heart J. 2020 Oct 31. pii: S0002-8703(20)30358.
     PubMed     Abstract available
     
     
     
143. WOSIK J, Clowse MEB, Overton R, Adagarla B, et al
     Impact of the COVID-19 Pandemic on Patterns of Outpatient Cardiovascular Care.
     Am Heart J. 2020 Oct 30. pii: S0002-8703(20)30360.
     PubMed     Abstract available
     
     
     
144. CHERTOW GM, Pergola PE, Agarwal R, Block GA, et al
     Cardiovascular Safety and Efficacy of Vadadust for the Treatment of Anemia in Non-Dialysis Dependent CKD: Design and Baseline Characteristics.
     Am Heart J. 2020 Oct 29. pii: S0002-8703(20)30354.
     PubMed     Abstract available
     
     
     
145. NOWAK RM, Jacobsen G, Jr AL, Peacock WF, et al
     Outpatient versus Observation/Inpatient Management of Emergency Department Patients Rapidly Ruled-out for Acute Myocardial Infarction: Findings from the HIGH-US Study.
     Am Heart J. 2020 Oct 27. pii: S0002-8703(20)30353.
     PubMed     Abstract available
     
     
     
146. VARSHNEY AS, Wang DE, Bhatt AS, Blood A, et al
     Characteristics of Clinical Trials Evaluating Cardiovascular Therapies for Coronavirus Disease 2019 Registered on ClinicalTrials.gov: A Cross Sectional Analysis.
     Am Heart J. 2020 Oct 26. pii: S0002-8703(20)30351.
     PubMed     Abstract available
     
     
     
147. NORDENSKJOLD AM, Agewall S, Atar D, Baron T, et al
     Randomized evaluation of beta blocker and ACE-inhibitor/angiotensin receptor blocker treatment in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA-BAT): Rationale and design.
     Am Heart J. 2020;231:96-104.
     PubMed     Abstract available
     
     
     
148. SALAH HM, Al'Aref SJ, Khan MS, Al-Hawwas M, et al
     Effect of sodium-glucose cotransporter 2 inhibitors on cardiovascular and kidney outcomes-Systematic review and meta-analysis of randomized placebo-controlled trials.
     Am Heart J. 2020;232:10-22.
     PubMed     Abstract available
     
     
     
149. NICHOLLS SJ, Lincoff AM, Bays HE, Cho L, et al
     Rationale and design of the CLEAR-outcomes trial: Evaluating the effect of Bempedoic acid on cardiovascular events in patients with statin intolerance.
     Am Heart J. 2020 Oct 23. pii: S0002-8703(20)30346.
     PubMed     Abstract available
     
     
     
150. SHAVADIA JS, Wilson J, Edmonston D, Platt A, et al
     Statins and atherosclerotic cardiovascular outcomes in patients on incident dialysis and with atherosclerotic heart disease.
     Am Heart J. 2020 Oct 20. pii: S0002-8703(20)30341.
     PubMed     Abstract available
     
     
     
151. GIBSON CM, Kastelein JJP, Phillips AT, Aylward PE, et al
     Rationale and design of ApoA-I event reducing in ischemic syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myoc
     Am Heart J. 2020 Oct 13. pii: S0002-8703(20)30335.
     PubMed     Abstract available
     
     
     
152. FANAROFF AC, Chen AY, van Diepen S, Mylod D, et al
     Association between intensive care unit utilization for patients with non-ST segment elevation myocardial infarction and patient experience.
     Am Heart J. 2020 Oct 9. pii: S0002-8703(20)30270.
     PubMed     Abstract available
     
     
     
153. WIGGERS H, Kober L, Gislason G, Schou M, et al
     The DANish randomized, double-blind, placebo controlled trial in patients with chronic HEART failure (DANHEART): A 2 x 2 factorial trial of hydralazine-isosorbide dinitrate in patients with chronic heart failure (H-HeFT) and metformin in patients with
     Am Heart J. 2020 Oct 8. pii: S0002-8703(20)30276.
     PubMed     Abstract available
     
     
     
154. PARADIES V, Zheng H, Bulluck H, Hausenloy DJ, et al
     Response to the letter to the editor regarding the study "Impact of time of onset of symptom of ST-segment elevation myocardial infarction on 1-year rehospitalization for heart failure and mortality" published in the American Heart Journal.
     Am Heart J. 2020;228:117-118.
     PubMed    
     
     
     
155. ROSSBERG N, Kirresh A, Ahmad M
     Letter to the editor regarding the study "Impact of time of onset of symptom of ST-segment elevation myocardial infarction on 1-year rehospitalization for heart failure and mortality" published in the American Heart Journal.
     Am Heart J. 2020;228:116.
     PubMed    
     
     
     
156. JAWITZ OK, Cox ML, Ranney D, Williams JB, et al
     Outcomes following revascularization with radial artery bypass grafts: Insights from the PREVENT-IV trial.
     Am Heart J. 2020;228:91-97.
     PubMed     Abstract available
     
     
     
157. AGGARWAL R, Chiu N, Pankayatselvan V, Shen C, et al
     Prevalence of angina and use of medical therapy among US adults: A nationally representative estimate.
     Am Heart J. 2020;228:44-46.
     PubMed     Abstract available
     
     
     
158. LI Y, Wang X, Bao D, Liao Z, et al
     Optimal antiplatelet therapy for prevention of gastrointestinal injury evaluated by ANKON magnetically controlled capsule endoscopy: Rationale and design of the OPT-PEACE trial.
     Am Heart J. 2020;228:8-16.
     PubMed     Abstract available
     
     
     September 2020
159. SKI CF, King-Shier K, Thompson DR
     Women are dying unnecessarily from cardiovascular disease.
     Am Heart J. 2020 Sep 30. pii: S0002-8703(20)30266.
     PubMed    
     
     
     
160. GRUBB AF, Pumill CA, Greene SJ, Wu A, et al
     Tobacco smoking in patients with heart failure and coronary artery disease: A 20-year experience at Duke University medical center.
     Am Heart J. 2020 Sep 24. pii: S0002-8703(20)30264.
     PubMed     Abstract available
     
     
     
161. ANGRAAL S, Caraballo C, Kahn P, Bhatnagar A, et al
     Geographical Affiliation with Top 10 NIH-Funded Academic Medical Centers and Differences Between Mortality from Cardiovascular Disease and Cancer.
     Am Heart J. 2020 Sep 17. pii: S0002-8703(20)30251.
     PubMed     Abstract available
     
     
     
162. BIGLER MR, Stoller M, Tschannen C, Grossenbacher R, et al
     Effect of permanent right internal mammary artery occlusion on right coronary artery supply: A randomized placebo-controlled clinical trial.
     Am Heart J. 2020 Sep 16. pii: S0002-8703(20)30259.
     PubMed     Abstract available
     
     
     August 2020
163. GUTIERREZ JA, Heizer GM, Jones WS, Rockhold FW, et al
     CYP2C19 status and risk of major adverse cardiovascular events in peripheral artery disease: Insights from the EUCLID Trial.
     Am Heart J. 2020;229:118-120.
     PubMed    
     
     
     
164. CHERY G, Kamp N, Kosinski AS, Schmidler GS, et al
     Prognostic value of myocardial fibrosis on cardiac magnetic resonance imaging in patients with ischemic cardiomyopathy: A systematic review.
     Am Heart J. 2020;229:52-60.
     PubMed     Abstract available
     
     
     
165. SHLOFMITZ E, Torguson R, Mintz GS, Zhang C, et al
     The IMPact on Revascularization Outcomes of intraVascular ultrasound-guided treatment of complex lesions and Economic impact (IMPROVE) trial: Study design and rationale.
     Am Heart J. 2020;228:65-71.
     PubMed     Abstract available
     
     
     
166. MUHLESTEIN JB, Muhlestein JB, Anderson JL, Bethea CF, et al
     Smartphone 12-lead ECG-Exciting but must be handled with care.
     Am Heart J. 2020;226:269.
     PubMed    
     
     
     
167. KATZ JN
     Back to the future-Are we ready for a randomized trial of surgical versus percutaneous revascularization in cardiogenic shock?
     Am Heart J. 2020;226:264-266.
     PubMed    
     
     
     
168. LINDOW T, Pahlm O
     Smartphone 12-lead ECG-Exciting but must be handled with care.
     Am Heart J. 2020;226:267-268.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: